Isolation of Mayaro Virus from a Venezuelan Patient with Febrile Illness, Arthralgias, and Rash: Further Evidence of Regional Strain Circulation and Possible Long-Term Endemicity
Abstract:Fifty-two febrile patients living in Barquisimeto, Venezuela, were screened for arbovirus infection by virus culture during an outbreak of what was thought to be Zika virus infection. We report identification of Mayaro virus (MAYV) on culture of plasma from one patient, an 18-year-old woman with acute febrile illness, arthralgias, and psoriasiform rash. The strain was sequenced and was found to be most closely related to a 1999 strain from French Guiana, which, in turn, was related to two 2014 strains from Hai… Show more
“…MAYV was identified in plasma samples from five patients. Two of the five cases have been previously reported (Ball et al, 2018;Lednicky et al, 2016), albeit as single cases, with the existence of two other strains noted in another paper (Blohm et al, 2019); the current manuscript combines data for all strains, and provides a unified phylogenetic and molecular clock analysis. In one case, the patient was found to be infected with both MAYV and DENV1 (Lednicky et al, 2016); a second case involved a dual infection with MAYV and CHIKV (Ball et al, 2018).…”
Section: Results and Commentmentioning
confidence: 89%
“…Methods for viral identification and phylogenetic analysis have been previously described ( Blohm et al, 2019 ; Mavian et al, 2017 ; Ball et al, 2018 ; Lednicky et al, 2016 ). In brief: plasma was separated and screened by rtRT-PCR for dengue, chikungunya, and zika viruses, with virus isolation then attempted in cell culture.…”
Section: Methodsmentioning
confidence: 99%
“…The primary vectors include mosquitoes within the genus Haemagogus , although Aedes spp may also be competent vectors ( Acosta-Ampudia et al, 2018 ). While originally isolated in Trinidad ( Anderson et al, 1957 ), the majority of MAYV cases have been reported from the Amazon basin region, including Brazil, Peru, and Ecuador ( Acosta-Ampudia et al, 2018 ; Halsey et al, 2013 ; Blohm et al, 2019 ; Mavian et al, 2017 ; Pan American Health Organization/World Health Organization, 2019 ; Auguste et al, 2015 ).…”
Mayaro virus (MAYV) is a mosquito-transmitted alphavirus that is being recognized with increasing frequency in South America. As part of ongoing surveillance of a school cohort in Haiti, we identified MAYV infections in 5 children across a 7-month time span, at two different school campuses. All had a history of fever, and three had headaches; none complained of arthralgias. On analysis of whole genome sequence data, three strains were genotype D, and two were genotype L; phylogenetic and molecular clock analysis was consistent with at least 3 independent introductions of the virus into Haiti, with ongoing transmission of a common genotype D strain in a single school. Our data highlight the clear potential for spread of the virus in the northern Caribbean and North America.
“…MAYV was identified in plasma samples from five patients. Two of the five cases have been previously reported (Ball et al, 2018;Lednicky et al, 2016), albeit as single cases, with the existence of two other strains noted in another paper (Blohm et al, 2019); the current manuscript combines data for all strains, and provides a unified phylogenetic and molecular clock analysis. In one case, the patient was found to be infected with both MAYV and DENV1 (Lednicky et al, 2016); a second case involved a dual infection with MAYV and CHIKV (Ball et al, 2018).…”
Section: Results and Commentmentioning
confidence: 89%
“…Methods for viral identification and phylogenetic analysis have been previously described ( Blohm et al, 2019 ; Mavian et al, 2017 ; Ball et al, 2018 ; Lednicky et al, 2016 ). In brief: plasma was separated and screened by rtRT-PCR for dengue, chikungunya, and zika viruses, with virus isolation then attempted in cell culture.…”
Section: Methodsmentioning
confidence: 99%
“…The primary vectors include mosquitoes within the genus Haemagogus , although Aedes spp may also be competent vectors ( Acosta-Ampudia et al, 2018 ). While originally isolated in Trinidad ( Anderson et al, 1957 ), the majority of MAYV cases have been reported from the Amazon basin region, including Brazil, Peru, and Ecuador ( Acosta-Ampudia et al, 2018 ; Halsey et al, 2013 ; Blohm et al, 2019 ; Mavian et al, 2017 ; Pan American Health Organization/World Health Organization, 2019 ; Auguste et al, 2015 ).…”
Mayaro virus (MAYV) is a mosquito-transmitted alphavirus that is being recognized with increasing frequency in South America. As part of ongoing surveillance of a school cohort in Haiti, we identified MAYV infections in 5 children across a 7-month time span, at two different school campuses. All had a history of fever, and three had headaches; none complained of arthralgias. On analysis of whole genome sequence data, three strains were genotype D, and two were genotype L; phylogenetic and molecular clock analysis was consistent with at least 3 independent introductions of the virus into Haiti, with ongoing transmission of a common genotype D strain in a single school. Our data highlight the clear potential for spread of the virus in the northern Caribbean and North America.
“…MAYV was isolated for the first time from the sera of forest workers in Trinidad and Tobago in 1954 [ 3 ]. Since then, several studies have revealed increasing activity of this virus in different Latin American countries, including Brazil, Peru, French Guiana, Ecuador, Bolivia, Colombia, Venezuela, Haiti, Panama, and Trinidad and Tobago [ 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 ].…”
Mayaro virus (MAYV) hijacks the host’s cell machinery to effectively replicate. The mitogen-activated protein kinases (MAPKs) p38, JNK, and ERK1/2 have emerged as crucial cellular factors implicated in different stages of the viral cycle. However, whether MAYV uses these MAPKs to competently replicate has not yet been determined. The aim of this study was to evaluate the impact of MAPK inhibition on MAYV replication using primary human dermal fibroblasts (HDFs) and HeLa cells. Viral yields in supernatants from MAYV-infected cells treated or untreated with inhibitors SB203580, SP600125, U0126, or Losmapimod were quantified using plaque assay. Additionally, viral protein expression was analyzed using immunoblot and immunofluorescence. Knockdown of p38⍺/p38β isoforms was performed in HDFs using the PROTACs molecule NR-7h. Our data demonstrated that HDFs are highly susceptible to MAYV infection. SB203580, a p38 inhibitor, reduced MAYV replication in a dose-dependent manner in both HDFs and HeLa cells. Additionally, SB203580 significantly decreased viral E1 protein expression. Similarly, knockdown or inhibition of p38⍺/p38β isoforms with NR-7h or Losmapimod, respectively, affected MAYV replication in a dose-dependent manner. Collectively, these findings suggest that p38 could play an important role in MAYV replication and could serve as a therapeutic target to control MAYV infection.
“…MAYV was isolated for the first time from the sera of forest workers in Trinidad and Tobago in 1954 [3]. Since then, several studies have revealed an increasing activity of this virus in different Latin American countries, including Brazil, Peru, French Guiana, Ecuador, Bolivia, Colombia, Venezuela, Haiti, Panama and Trinidad and Tobago [4][5][6][7][8][9][10][11][12][13][14].…”
Mayaro virus (MAYV) hijacks the host´s cell machinery to effectively replicate. The mitogen-activated protein kinases (MAPKs) p38, JNK and ERK1/2 have emerged as crucial cellular factors implicated in different stages of the viral cycle. However, whether MAYV uses these MAPKs to competently replicate has not yet been determined. The aim of this study was to evaluate the impact of MAPKs inhibition on MAYV replication using primary human dermal fibroblasts (HDFs) and HeLa cells. Viral yields in supernatants from MAYV-infected cells treated or untreated with inhibitors SB203580, SP600125, U0126 or Losmapimod were quantified using plaque assay. Also, viral protein expression was analyzed using immunoblot and immunofluorescence. Knockdown of p38⍺/p38β isoforms was performed in HDFs using the PROTACs molecule NR-7h. Our data demonstrated that HDFs are highly susceptible to MAYV infection. SB203580, a p38 inhibitor, reduced MAYV replication in a dose-dependent manner in both HDFs and HeLa cells. Additionally, SB203580 significantly decreased viral E1 protein expression. Similarly, knockdown or inhibition of p38⍺/p38β isoforms with NR-7h or Losmapimod, respectively, affected MAYV replication in a dose-dependent manner. Collectively, these findings suggest that p38 could play an important role in MAYV replication and could serve as a therapeutic target to control MAYV infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.